80 related articles for article (PubMed ID: 9176520)
1. A novel, membrane receptor-based retroviral vector for Fanconi anemia group C gene therapy.
Machl AW; Planitzer S; Kubbies M
Gene Ther; 1997 Apr; 4(4):339-45. PubMed ID: 9176520
[TBL] [Abstract][Full Text] [Related]
2. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
[TBL] [Abstract][Full Text] [Related]
4. Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the fanconi anemia C gene after conditioning with low-dose irradiation.
Kang EM; Hanazano Y; Frare P; Vanin EF; De Witte M; Metzger M; Liu JM; Tisdale JF
Mol Ther; 2001 Jun; 3(6):911-9. PubMed ID: 11407905
[TBL] [Abstract][Full Text] [Related]
5. Increased gene transfer into human CD34+ progenitor cells using retroviral vectors produced by a canine packaging cell line.
Bauer G; Sauter S; Ibanez C; Rice CR; Valdez P; Jolly D; Kohn DB
Biol Blood Marrow Transplant; 1998; 4(3):119-27. PubMed ID: 9923409
[TBL] [Abstract][Full Text] [Related]
6. Retroviral mediated gene transfer of the Fanconi anemia complementation group C gene to hematopoietic progenitors of group C patients.
Liu JM; Young NS; Walsh CE; Cottler-Fox M; Carter C; Dunbar C; Barrett AJ; Emmons R
Hum Gene Ther; 1997 Sep; 8(14):1715-30. PubMed ID: 9322874
[TBL] [Abstract][Full Text] [Related]
7. A rapid method for retrovirus-mediated identification of complementation groups in Fanconi anemia patients.
Chandra S; Levran O; Jurickova I; Maas C; Kapur R; Schindler D; Henry R; Milton K; Batish SD; Cancelas JA; Hanenberg H; Auerbach AD; Williams DA
Mol Ther; 2005 Nov; 12(5):976-84. PubMed ID: 16084127
[TBL] [Abstract][Full Text] [Related]
8. A comparative evaluation of gene transfer into blood cells using the same retroviral backbone for independent expression of the EGFP and deltaLNGFR marker genes.
Giaretta I; Madeo D; Bonaguro R; Cappellari A; Rodeghiero F; Giorgio P
Haematologica; 2000 Jul; 85(7):680-9. PubMed ID: 10897118
[TBL] [Abstract][Full Text] [Related]
9. Preclinical protocol for in vivo selection of hematopoietic stem cells corrected by gene therapy in Fanconi anemia group C.
Noll M; Bateman RL; D'Andrea AD; Grompe M
Mol Ther; 2001 Jan; 3(1):14-23. PubMed ID: 11162306
[TBL] [Abstract][Full Text] [Related]
10. Rapid analysis and efficient selection of human transduced primitive hematopoietic cells using the humanized S65T green fluorescent protein.
Mazurier F; Moreau-Gaudry F; Maguer-Satta V; Salesse S; Pigeonnier-Lagarde V; Ged C; Belloc F; Lacombe F; Mahon FX; Reiffers J; de Verneuil H
Gene Ther; 1998 Apr; 5(4):556-62. PubMed ID: 9614582
[TBL] [Abstract][Full Text] [Related]
11. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC).
Liu JM; Kim S; Read EJ; Futaki M; Dokal I; Carter CS; Leitman SF; Pensiero M; Young NS; Walsh CE
Hum Gene Ther; 1999 Sep; 10(14):2337-46. PubMed ID: 10515453
[TBL] [Abstract][Full Text] [Related]
12. A functionally active retrovirus vector for gene therapy in Fanconi anemia group C.
Walsh CE; Grompe M; Vanin E; Buchwald M; Young NS; Nienhuis AW; Liu JM
Blood; 1994 Jul; 84(2):453-9. PubMed ID: 7517716
[TBL] [Abstract][Full Text] [Related]
13. The Fanconi anemia complementation group C gene (FAC) suppresses transformation of mutant fibroblasts by the SV40 virus.
Liu JM; Poiley J; Devetten M; Kajigaya S; Walsh CE
Biochem Biophys Res Commun; 1996 Jun; 223(3):685-90. PubMed ID: 8687457
[TBL] [Abstract][Full Text] [Related]
14. Functional correction of Fanconi anemia group A hematopoietic cells by retroviral gene transfer.
Fu KL; Foe JR; Joenje H; Rao KW; Liu JM; Walsh CE
Blood; 1997 Nov; 90(9):3296-303. PubMed ID: 9345011
[TBL] [Abstract][Full Text] [Related]
15. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the Fanconi's anemia protein FAC in a pathway that signals to the cyclin B/cdc2 kinase.
Kruyt FA; Dijkmans LM; Arwert F; Joenje H
Cancer Res; 1997 Jun; 57(11):2244-51. PubMed ID: 9187128
[TBL] [Abstract][Full Text] [Related]
17. Multiparameter-fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells.
McCowage GB; Phillips KL; Gentry TL; Hull S; Kurtzberg J; Gilboa E; Smith C
Exp Hematol; 1998 Apr; 26(4):288-98. PubMed ID: 9546311
[TBL] [Abstract][Full Text] [Related]
18. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T; Mizuguchi H
Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730
[TBL] [Abstract][Full Text] [Related]
19. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.
Ferrer M; de Winter JP; Mastenbroek DC; Curiel DT; Gerritsen WR; Giaccone G; Kruyt FA
Cancer Gene Ther; 2004 Aug; 11(8):539-46. PubMed ID: 15192709
[TBL] [Abstract][Full Text] [Related]
20. Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with Fanconi anemia.
González-Murillo A; Lozano ML; Alvarez L; Jacome A; Almarza E; Navarro S; Segovia JC; Hanenberg H; Guenechea G; Bueren JA; Río P
Hum Gene Ther; 2010 May; 21(5):623-30. PubMed ID: 20001454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
